Adore Beauty (ASX:ABY) has guided FY27 EBITDA to $9-13m. After a torrid half decade post IPO, is the company finally delivering for investors?
Charlie Youlden
Pacific Edge’s (ASX:PEB) FY26 revenue halved, but a news of a draft Medicare LCD for Cxbladder was good news
Beach Energy (ASX:BPT) sells its Artisan gas discovery to Amplitude for A$70m cash plus royalty, freeing more than A$500m of planned Otway capital.
Delorean Corporation (ASX:DEL) hits 75% completion at SA1 Salisbury, with first biomethane injection into the Adelaide gas network targeted for November 2026.
Alcidion (ASX:ALC) has signed its A$35m UHSussex EPR contract with A$8.5m recognised in FY26 via an upfront licence fee.
Charter Hall (ASX:CHC) upgraded its FY26 OEPS guidance to $1.03 per share off the back of $6.5bn institutional inflows and FUM rising to $74.7 billion.
ERoad (ASX:ERD) posts NZ$161m FY26 loss after North America write-down, but ANZ momentum and the eRUC opportunity in New Zealand look promising in FY27.
Today's investment landscape is a far cry from five years ago. At the time, many investors would purchase a few stocks, sit on them, and review their stock portfolio monthly. Now? Investors use apps a number of times every day. They're watching stocks and tech stocks one minute, then Bitcoin prices, or gold charts, the…
Arafura Rare Earths (ASX:ARU) launches A$350m placement at A$0.260 after Nolans FID, lifting pro forma cash to A$911m and clearing equity funding.
Ainsworth Game Technology (ASX:AGI) flagged a A$1 million H1CY26 pre-tax profit as North American revenue slid 24%.
